ORPEA : The technical rebound to run out of steam
| Entry price | Target | Stop-loss | Potential |
|---|
|
€99.72 |
€85 |
€107.5 |
+14.76% |
|---|
In close proximity to the technical resistance zone that has been tested over several trading sessions, stocks in Orpéa SA could experience a pullback over the coming trading sessions towards technical support levels based on daily closing prices.
Strengths● Analysts covering this company mostly recommend stock overweighting or purchase.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The group usually releases earnings worse than estimated.
● With an enterprise value anticipated at 3.7 times the sales for the current fiscal year, the company turns out to be overvalued.
● The company is not the most generous with respect to shareholders' compensation.
● For the last few months, analysts have been revising downwards their earnings forecast.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
ORPEA 
